Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To determine the efficacy of nebulized 5% hypertonic saline on cough severity and quality of life, in children with non-CF CSLD. Secondary Aims: To determine the: 1. Efficacy of nebulized 5% hypertonic saline on airway microbiome, pulmonary exacerbation rate, healthcare utilization, and rescue antibiotics. 2. Efficacy of nebulized 5% hypertonic saline on lung function 3. Adverse effects of nebulized 5% hypertonic saline in children
Epistemonikos ID: cdc49431154162b2b6480ec98bd620b2394b2b5e
First added on: May 08, 2024